Topical microbicides become topical
Moore, J.P.
New England Journal of Medicine 352(3): 298-300
2005
ISSN/ISBN: 0028-4793 PMID: 15659734 DOI: 10.1056/nejmcibr043727Document Number: 240546
Document emailed within 0-6 h
Related Documents
Dhawan, D.; Keller, M.; Klotman, M.E. 2006: Topical microbicides: the time has come Aids Reader 16(3): 144-148; 155-158 161; Discussion 148: 156-157Chirenje, Z.M. 2001: Topical vaginal microbicides in HIV/STI prevention Central African Journal of Medicine 47(8): 209-210
Chirenje, Z.M. 2001: Topical vaginal microbicides in HIV/STI prevention Central African Journal of Medicine 47(8): 209-210
Woodsong, C. 2004: Covert use of topical microbicides: implications for acceptability and use Perspectives on Sexual and Reproductive Health 36(3): 127-131
Mauck, C.; Rosenberg, Z.; Van Damme, L. 2001: Recommendations for the clinical development of topical microbicides: an update Aids 15(7): 857-868
Van Damme, L. 2000: Clinical research with topical microbicides as a potential HIV prevention method Aids Reader 10(9): 552-554
Turpin, J.A. 2002: Considerations and development of topical microbicides to inhibit the sexual transmission of HIV Expert Opinion on Investigational Drugs 11(8): 1077-1097
Sánchez-Rodríguez, J.; Vacas-Córdoba, E.; Gómez, R.; De La Mata, F.Javier.; Muñoz-Fernández, M.Ángeles. 2015: Nanotech-derived topical microbicides for HIV prevention: the road to clinical development Antiviral Research 113: 33-48
Abner, S.R.; Guenthner, P.C.; Guarner, J.; Hancock, K.A.; Cummins, J.E.; Fink, A.; Gilmore, G.Thomas.; Staley, C.; Ward, A.; Ali, O.; Binderow, S.; Cohen, S.; Grohskopf, L.A.; Paxton, L.; Hart, C.E.; Dezzutti, C.S. 2005: A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection Journal of Infectious Diseases 192(9): 1545-1556
Friend, D.R.; Kiser, P.F. 2013: Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned Antiviral Research 99(3): 391-400
Scordi-Bello, I.A.; Mosoian, A.; He, C.; Chen, Y.; Cheng, Y.; Jarvis, G.A.; Keller, M.J.; Hogarty, K.; Waller, D.P.; Profy, A.T.; Herold, B.C.; Klotman, M.E. 2005: Candidate sulfonated and sulfated topical microbicides: comparison of anti-human immunodeficiency virus activities and mechanisms of action Antimicrobial Agents and ChemoTherapy 49(9): 3607-3615
Leyden, J.J.; McGinley, K.; Mills, O.H.; Kligman, A.M. 1980: Topical antibiotics and topical antimicrobial agents in acne therapy Acta Dermato-Venereologica. Supplementum Suppl 89: 75-82
Keller, M.J.; Klotman, M.E.; Herold, B.C. 2003: Development of topical microbicides for prevention of human immunodeficiency virus and herpes simplex virus American Journal of Reproductive Immunology 49(5): 279-284
Cheshenko, N.; Keller, M.J.; MasCasullo, V.; Jarvis, G.A.; Cheng, H.; John, M.; Li, J-Hua.; Hogarty, K.; Anderson, R.A.; Waller, D.P.; Zaneveld, L.J.D.; Profy, A.T.; Klotman, M.E.; Herold, B.C. 2004: Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread Antimicrobial Agents and ChemoTherapy 48(6): 2025-2036
Booranapong, W.; Kosrirukvongs, P.; Prabhasawat, P.; Srivannaboon, S.; Suttiprakarn, P. 2004: Comparison of topical lomefloxacin 0.3 per cent versus topical ciprofloxacin 0.3 per cent for the treatment of presumed bacterial corneal ulcers Journal of the Medical Association of Thailand 87(3): 246-254
Venkatarajan, S.; LeLeux, T.M.; Yang, D.; Rosen, T.; Orengo, I. 2010: Porokeratosis of Mibelli: Successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil Dermatology Online Journal 16(12): 10
Puvabanditsin, P.; Vongtongsri, R. 2006: Efficacy of topical vitamin C derivative (VC-PMG) and topical vitamin E in prevention and treatment of UVA suntan skin Journal of the Medical Association of Thailand 89 Suppl. 3: S65-S68
Smith, K.C.; Lebwohl, M. 2000: Topical antipsoriatics Skin Therapy Letter 5(2): 1-2
Sibbald, R.Gary. 2003: Topical antimicrobials Ostomy/Wound Management 49(5a Suppl): 14-18
Belisario, J.C. 1973: Topical use of 5-fluorouracil Medical Journal of Australia 2(2): 91